Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice Corrigendum in /10.3892/ijmm.2019.4091

Wu,Min; Ai,Wenting; Chen,Lin; Zhao,Sihai; Liu,Enqi

doi:10.3892/ijmm.2016.2457

Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice

Corrigendum in: /10.3892/ijmm.2019.4091

Authors:
- Min Wu
- Wenting Ai
- Lin Chen
- Sihai Zhao
- Enqi Liu
View Affiliations

Affiliations: Laboratory Animal Center, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi 710061, P.R. China, Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China, Department of Pathology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China
Published online on: January 12, 2016 https://doi.org/10.3892/ijmm.2016.2457
Pages: 565-574
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study was carried out in order to investigate bone dysfunction and the involvement of bradykinin receptors and the Eph/Ephrin signaling pathway in osteoblasts and in mice with diabetes-related osteoporosis in response to exposure to high glucose. Osteogenic transdifferentiation was inhibited when the osteoblasts were exposed to high glucose, and the expression levels of bone formation-related genes [Runx2 and alkaline phosphatase (ALP)] were decreased, while those of bone resorption-related genes [matrix metalloproteinase (MMP)9 and carbonic anhydrase II (CAII)] were increased. Moreover, the mRNA and protein expression levels of bradykinin receptor B1 (BK1R)/bradykinin receptor B2 (BK2R) and EphB2/EphrinB2 were significantly decreased in the osteoblasts following exposure to high glucose. Intriguingly, the interaction between BK2R and EphB2/EphrinB2 was confirmed, and BK2R loss-of-function significantly decreased the mRNA and protein expression levels of EphB2/EphrinB4. In vivo, hyperglycemia induced the disequilibrium of calcium homeostasis through the inhibition of bone formation and the acceleration of bone resorption, which was manifested by the reduction of trabecular bone mass of the primary and secondary spongiosa, as well as by the increase in the number of mature osteoclasts throughout the proximal tibial metaphysis in mice with diabetes-related osteoporosis. Furthermore, the mRNA and protein expression levels of BK1R/BK2R and EphB2/EphrinB2 in the tibias of the mice with diabetes-related osteoporosis were significantly decreased. These results demonstrate that bradykinin receptors and the EphB4/EphrinB2 pathway mediate the development of complications in mice with diabetes-related osteoporosis and suggest that the inactivation of bradykinin receptors and the EphB4/EphrinB2 pathway enhance the severity of complications in mice with diabetes-related osteoporosis.

View Figures

View References

1	Cummings SR and Melton LJ: Epidemiology and outcomes of osteoporotic fractures. Lancet. 359:1761–1767. 2002. View Article : Google Scholar : PubMed/NCBI
2	Hamann C, Kirschner S, Günther KP and Hofbauer LC: Bone, sweet bone - osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol. 8:297–305. 2012. View Article : Google Scholar : PubMed/NCBI
3	Armas LA, Akhter MP, Drincic A and Recker RR: Trabecular bone histomorphometry in humans with type 1 diabetes mellitus. Bone. 50:91–96. 2012. View Article : Google Scholar
4	Loureiro MB, Ururahy MA, Freire-Neto FP, Oliveira GH, Duarte VM, Luchessi AD, Brandão-Neto J, Hirata RD, Hirata MH, Maciel-Neto JJ, et al: Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 103:452–457. 2014. View Article : Google Scholar : PubMed/NCBI
5	Janghorbani M, Feskanich D, Willett WC and Hu F: Prospective study of diabetes and risk of hip fracture: The Nurses' Health Study. Diabetes Care. 29:1573–1578. 2006. View Article : Google Scholar : PubMed/NCBI
6	Diao TY, Pan H, Gu SS, Chen X, Zhang FY, Wong MS and Zhang Y: Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes. J Bone Miner Metab. 32:261–270. 2014. View Article : Google Scholar
7	Rao Sirasanagandla S, Ranganath Pai Karkala S, Potu BK and Bhat KM: Beneficial effect of Cissus quadrangularis Linn. on osteopenia associated with streptozotocin-induced type 1 diabetes mellitus in male Wistar rats. Adv Pharmacol Sci. 2014:4830512014.PubMed/NCBI
8	Fu C, Zhang X, Ye F and Yang J: High insulin levels in KK-Ay diabetic mice cause increased cortical bone mass and impaired trabecular micro-structure. Int J Mol Sci. 16:8213–8226. 2015. View Article : Google Scholar : PubMed/NCBI
9	Guan CC, Yan M, Jiang XQ, Zhang P, Zhang XL, Li J, Ye DX and Zhang FQ: Sonic hedgehog alleviates the inhibitory effects of high glucose on the osteoblastic differentiation of bone marrow stromal cells. Bone. 45:1146–1152. 2009. View Article : Google Scholar : PubMed/NCBI
10	Wittrant Y, Gorin Y, Woodruff K, Horn D, Abboud HE, Mohan S and Abboud-Werner SL: High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone. 42:1122–1130. 2008. View Article : Google Scholar : PubMed/NCBI
11	Irie N, Takada Y, Watanabe Y, Matsuzaki Y, Naruse C, Asano M, Iwakura Y, Suda T and Matsuo K: Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem. 284:14637–14644. 2009. View Article : Google Scholar : PubMed/NCBI
12	Matsuo K and Otaki N: Bone cell interactions through Eph/ephrin: Bone modeling, remodeling and associated diseases. Cell Adhes Migr. 6:148–156. 2012. View Article : Google Scholar
13	Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lavigne M and Martel-Pelletier J: Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes. Arthritis Res Ther. 11:R1192009. View Article : Google Scholar : PubMed/NCBI
14	Cheng S, Zhao SL, Nelson B, Kesavan C, Qin X, Wergedal J, Mohan S and Xing W: Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice. PLoS One. 7:e328872012. View Article : Google Scholar : PubMed/NCBI
15	Arthur A, Zannettino A, Panagopoulos R, Koblar SA, Sims NA, Stylianou C, Matsuo K and Gronthos S: EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone. 48:533–542. 2011. View Article : Google Scholar
16	Watanabe T, Sato Y, Saito D, Tadokoro R and Takahashi Y: EphrinB2 coordinates the formation of a morphological boundary and cell epithelialization during somite segmentation. Proc Natl Acad Sci USA. 106:7467–7472. 2009. View Article : Google Scholar : PubMed/NCBI
17	Xing W, Kim J, Wergedal J, Chen ST and Mohan S: Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1. Mol Cell Biol. 30:711–721. 2010. View Article : Google Scholar :
18	Davy A, Aubin J and Soriano P: Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev. 18:572–583. 2004. View Article : Google Scholar : PubMed/NCBI
19	Davy A, Bush JO and Soriano P: Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol. 4:e3152006. View Article : Google Scholar : PubMed/NCBI
20	Stiffel V, Amoui M, Sheng MH, Mohan S and Lau KH: EphA4 receptor is a novel negative regulator of osteoclast activity. J Bone Miner Res. 29:804–819. 2014. View Article : Google Scholar
21	Yamada T, Yuasa M, Masaoka T, Taniyama T, Maehara H, Torigoe I, Yoshii T, Shinomiya K, Okawa A and Sotome S: After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate. Bone. 57:343–354. 2013. View Article : Google Scholar : PubMed/NCBI
22	Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T and Matsuo K: Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 4:111–121. 2006. View Article : Google Scholar : PubMed/NCBI
23	Campbell DJ: The renin-angiotensin and the kallikrein-kinin systems. Int J Biochem Cell Biol. 35:784–791. 2003. View Article : Google Scholar : PubMed/NCBI
24	Campbell DJ: The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol. 28:1060–1065. 2001. View Article : Google Scholar
25	Gonçalves-Zillo TO, Pugliese LS, Sales VM, Mori MA, Squaiella-Baptistão CC, Longo-Maugéri IM, Lopes JD, de Oliveira SM, Monteiro AC and Pesquero JB: Increased bone loss and amount of osteoclasts in kinin B1 receptor knockout mice. J Clin Periodontol. 40:653–660. 2013. View Article : Google Scholar : PubMed/NCBI
26	Kakoki M, Sullivan KA, Backus C, Hayes JM, Oh SS, Hua K, Gasim AM, Tomita H, Grant R, Nossov SB, et al: Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci USA. 107:10190–10195. 2010. View Article : Google Scholar : PubMed/NCBI
27	Tsukamoto T, Li X, Morita H, Minowa T, Aizawa T, Hanagata N and Demura M: Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells. PLoS One. 8:e758312013. View Article : Google Scholar : PubMed/NCBI
28	Bi Y, Nielsen KL, Kilts TM, Yoon A, A Karsdal M, Wimer HF, Greenfield EM, Heegaard AM and Young MF: Biglycan defi-ciency increases osteoclast differentiation and activity due to defective osteoblasts. Bone. 38:778–786. 2006. View Article : Google Scholar
29	Pennisi A, Ling W, Li X, Khan S, Shaughnessy JD Jr, Barlogie B and Yaccoby S: The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood. 114:1803–1812. 2009. View Article : Google Scholar : PubMed/NCBI
30	Pasquale EB: Eph-ephrin bidirectional signaling in physiology and disease. Cell. 133:38–52. 2008. View Article : Google Scholar : PubMed/NCBI
31	Shimizu E, Tamasi J and Partridge NC: Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB. J Dent Res. 91:268–274. 2012. View Article : Google Scholar :
32	Brechter AB and Lerner UH: Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression. Arthritis Rheum. 56:910–923. 2007. View Article : Google Scholar : PubMed/NCBI
33	Brechter AB, Persson E, Lundgren I and Lerner UH: Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases. Bone. 43:72–83. 2008. View Article : Google Scholar : PubMed/NCBI
34	Srivastava S, Sharma K, Kumar N and Roy P: Bradykinin regulates osteoblast differentiation by Akt/ERK/NFκB signaling axis. J Cell Physiol. 229:2088–2105. 2014. View Article : Google Scholar : PubMed/NCBI
35	Duka I, Shenouda S, Johns C, Kintsurashvili E, Gavras I and Gavras H: Role of the B(2) receptor of bradykinin in insulin sensitivity. Hypertension. 38:1355–1360. 2001. View Article : Google Scholar : PubMed/NCBI